← Back to patent-cliff list
NX-9
Tier C — Watch / tradeNX-9
Nextrast Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：胃肠道癌症, 胃肠疾病
Regional status
US
Phase II
2020-08-01
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of NX-9?
Approved indications include: 胃肠道癌症, 胃肠疾病.
When does the NX-9 patent expire?
No public expiry year is available for NX-9 yet; this page updates once verified.
How do I get a quote for NX-9 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06